4
Changes in Ownership
Vera Therapeutics, Inc. Filed Acc 0001209191-22-061178
Chief Development Officer sold 19,711 shares at an average $18.26 ($359,973)
- Chief Development Officer acquired 19,711 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Curley Joanne · Chief Development Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-12-12 | Exercise or conversion : show line 1 in the form | +6,900 | $11.00 | $75,900 | 33,721 | D |
| 2022-12-12 | Sale : show line 2 in the form | −6,900 | $18.25 | $125,924 | 26,821 | D |
| 2022-12-13 | Exercise or conversion : show line 3 in the form | +11,733 | $11.00 | $129,063 | 38,554 | D |
| 2022-12-13 | Sale : show line 4 in the form | −11,733 | $18.28 | $214,441 | 26,821 | D |
| 2022-12-13 | Exercise or conversion : show line 5 in the form | +1,078 | $6.37 | $6,870 | 27,899 | D |
| 2022-12-13 | Sale : show line 6 in the form | −1,078 | $18.19 | $19,609 | 26,821 | D |
| Open-market sales · 19,711 sh · avg $18.26 · $359,973 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-12-12 | Exercise or conversion : show line 7 in the form Stock Options (right to buy) | −6,900 | 77,117 | D |
| 2022-12-13 | Exercise or conversion : show line 8 in the form Stock Option (right to buy) | −11,733 | 65,384 | D |
| 2022-12-13 | Exercise or conversion : show line 9 in the form Stock Options (right to buy) | −1,078 | 8,639 | D |
Loading xslF345X03/doc4.xml…